21 22 July 2023
Park Hyatt, Hyderabad
The next frontier for India Pharma Inc is transforming into a value-driven, innovation-focused industry. This requires the industry to leverage its experience and expertise gained as a leading generics manufacturer towards the development of new molecules and biosimilars.
Fortuitously, many global companies across sectors, including pharma are looking at India to set up cutting-edge R&D centres to strengthen their capabilities and capture new markets, driven by factors such as market opportunity, technical expertise, cost efficiency, proactive government policies, as well as talented and dynamic workforce.
Therefore, FDD Conclave 2023 will bring the FR&D community together to discuss how India Pharma Inc needs to leverage its existing strengths and build new capabilities to develop of innovative and differentiated pharma products, complex drugs or biologics and biosimilars across a range of indications for its next phase of growth.
FR&D leaders will also highlight evidence-based strategies and approaches to develop novel formulations and drug delivery systems which will help create intellectual property, enhance life-cycle management, and amplify cost and market differentiation.
The leaders will also examine the impact of recent government initiatives, regulations and policies to help promote innovation in pharma R&D and help India secure and sustain a key position in the global pharma R&D landscape.
Director and EVP (Technical Operations, Natco Pharma
Head R&D (Formulations), Biocon
VP-FR&D, Sun Pharma
Sr VP and Head R&D, Biological E
AVP-R&D, Biological E
Formulation Expert, Sigachi Industries
Technical Sales, CILICANT
Director- Pharmaceutical Process, Romaco
Sr. Manager – Business Development, Ami Polymer
VP & Head-R&D Biotech, Bharat Serums & Vaccines
Senior Technical Application Expert, Merck Lifescience, India
MD, Nitika Pharmaceutical Specialities
Sr VP R&D, Auro Vaccines
EVP - Pharma R&D, Lupin
EVP, MSN Laboratories
VP & Head - R&D (Injectables and Ophthalmics), Amneal Pharmaceuticals
Head of Application, Asia and Middle East of Africa Biopharma, Avantor Performance Materials Korea
Sr VP R&D, Hetero Drugs
VP & Head- Developability & Formulations, Sai Life Sciences
Business Development Lead, CEPI
Leaders and Experts in:
To be announced shortly